Casinvent Pharma A.s.

Casinvent Pharma A.s. is an SME in Brno, Czech Republic that has taken part in 2 EU-funded projects since 2025, receiving €485k in EU funding and leading 1 as coordinator.

EU funding received€485k
EU projects2
As coordinator1
Running now2
First EU project2025
Latest project2026
CountryCzech Republic
EU registration (PIC)881947184
On this page · 4 sections→

Where the EU money came from

Funding by EU programme. Amounts are Casinvent Pharma A.s.'s own share of each project, not the project's full budget.

  • Horizon Europe€485k · 2 projects

Projects

2 EU-funded projects, newest first. Casinvent Pharma A.s. led 1 of them as coordinator. Each links to the official record.

  • REACT-CK1Coordinator

    Revolutionizing AML Therapy - A First-in-Class CK1 Inhibitor for Relapsed Refractory Patients

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €485ktheir share
  • CEIPEXAssociated partner

    CEItec Postdoctoral EXperts

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime